Clinical Trial Update: Phase II Study of Ofatumumab Plus Ifosfamide, Carboplatin, Etoposide (ICE) or Dexamethasone, Cytarabine, Cisplatin (DHAP) Chemotherapy Regimen in Relapsed/ Refractory Diffuse Large B Cell Lymphoma (DLBCL) [Phase 2]

View source ↗

Summary

This Phase II trial evaluated the combination of ofatumumab with ICE or DHAP chemotherapy in relapsed/refractory diffuse large B-cell lymphoma; the study is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Arzerra (ofatumumab)
• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• CYTARABINE (CYTARABINE)
• DEXAMETHASONE (Dexamethasone)
• Etoposide (Etoposide)
• IFOSFAMIDE (IFOSFAMIDE)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lymphoma, Large-Cell, Diffuse | Phase 2 | Status: COMPLETED | Results posted: 2012-09-05